Pages that link to "Item:Q6788"

The following pages link to adverse effect (Q6788):

Displayed 38 items.

• Use of industrial liquid silicone: a scoping review (Q27636) ‎ (← links)
• How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe? (Q28769) ‎ (← links)
• Voiding Dysfunction in Transgender Patients: What We Know and What We Do Not Know (Q28906) ‎ (← links)
• Reproductive health in trans and gender diverse patients: Transgender medicine: contextual trans gynecology (Q28954) ‎ (← links)
• Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective (Q29339) ‎ (← links)
• Gender-affirming therapy reshapes the immune systems of trans men (Q29344) ‎ (← links)
• Immune system adaptation during gender-affirming testosterone treatment (Q29405) ‎ (← links)
• Safe and supportive prescribing in transgender and non-binary patients with cancer (Q29504) ‎ (← links)
• Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs (Q29626) ‎ (← links)
• Transgender patients and gender-affirming hormone therapy through the mid-life (Q29890) ‎ (← links)
• The Role of Sex and Gender in Transgender Bone and Other Musculoskeletal Health (Q29977) ‎ (← links)
• Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial (Q30091) ‎ (← links)
• Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults (Q30162) ‎ (← links)
• Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study (Q30289) ‎ (← links)
• (Q30500) ‎ (← links)
• (Q30639) ‎ (← links)
• (Q30832) ‎ (← links)
• (Q30894) ‎ (← links)
• (Q30912) ‎ (← links)
• (Q31120) ‎ (← links)
• (Q31131) ‎ (← links)
• (Q31140) ‎ (← links)
• (Q31256) ‎ (← links)
• (Q31461) ‎ (← links)
• The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals (Q31792) ‎ (← links)
• adverse event (Q31934) ‎ (← links)
• (Q31980) ‎ (← links)
• (Q32121) ‎ (← links)
• (Q32134) ‎ (← links)
• (Q32171) ‎ (← links)
• (Q32575) ‎ (← links)
• (Q32719) ‎ (← links)
• (Q32922) ‎ (← links)
• (Q33318) ‎ (← links)
• (Q33329) ‎ (← links)
• (Q33426) ‎ (← links)
• (Q33462) ‎ (← links)
• (Q33569) ‎ (← links)